Impatient patients turn to online ‘buyers club’ for new drugs

Frustrated by delays in new medicines reaching their own country, a small but growing number of patients are turning to an online broker that bills itself as a legal version of the Dallas Buyers Club. While regulators warn of the risk of buying drugs online, the Amsterdam-based Social Medwork sees its

The U.S. Food and Drug Administration excluded three drug substances

The U.S. Food and Drug Administration on Monday proposed excluding three substances from a list of ingredients that could be used to manufacture compounded medications in bulk for use by hospitals and doctors' offices. The action was the first time the regulator has moved to exclude any substance from a list